Role of HIV-1 Tat and CC Chemokine MIP-1α in the pathogenesis of HIV associated central nervous system disorders

References

• Aksamit AJ, Gendelman HE, Orenstein JM, Pezeshkpour GH. AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohisto-chemistry. Neurology 1990; 40: 1073–1078
   PubMedGoogle Scholar
• Biswas DK, Salas TR, Wang F, Ahlers CM, Dezube BJ, Pardee AB. A tat induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J Virol 1995; 69: 7347–7354
   Google Scholar
• Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Bed) 1987; 75: 185–198
   PubMed Web of Science ®Google Scholar
• Chirmule N, Than S, Khan SA, Pahwa S. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol 1995; 69: 492–498
   PubMed Web of Science ®Google Scholar
• Chowdhury M, Taylor JP, Tada H, Rappaport J, Wong-Staal F, Amini S, Khalili K. Regulation of the Human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene 1990; 5: 1737–1742
   PubMedGoogle Scholar
• Chowdhury M, Taylor JP, Chang C-F, Rappaport J, Khalili K. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 by Tat. J Virol 1992; 66: 7355–7361
   PubMedGoogle Scholar
• Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811–1815
   PubMed Web of Science ®Google Scholar
• Conant K, Garzino-Demo A, Nath A, Mc Arthur JC, Halliday W, Power C, Gallo RC, Major EO. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998; 95: 3117–3121
   PubMed Web of Science ®Google Scholar
• Cupp C, Taylor JP, Khalili K, Amini S. Evidence for stimulation of the transforming growth factor β-l promoter by HIV-1 Tat in cells derived from CNS. Oncogene 1993; 8: 2231–2236
   PubMed Web of Science ®Google Scholar
• Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993; 67: 277–287
   PubMed Web of Science ®Google Scholar
• Gabuzda DH, Hirsch MS. Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann Intern Med 1987; 107: 383–391
   PubMed Web of Science ®Google Scholar
• Gallia GL, Darbinian N, Tretiakova A, Ansari SA, Rappaport J, Brady J, Wortman MJ, Johnson EM, Khalili K. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc Natl Acad Sci USA 1999; 96: 11572–11577
   PubMedGoogle Scholar
• Georgsson G. Neuropathologic aspects of lentiviral infections. Ann NY Acad Sci 1994; 724: 50–67
   PubMed Web of Science ®Google Scholar
• Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, Bock P, Che M, Limoges J, Gendelman HE, Mackay CR. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J Virol 1998; 72: 3351–3361
   Google Scholar
• Glass JD, Fedor H, Wesselingh SL, Mc Arthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995; 38: 755–762
   PubMed Web of Science ®Google Scholar
• Gorry PR, Howard JL, Churchill MJ, Anderson JL, Cunningham A, Adrian D, Mc Phee DA, Purcell DF. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev. J Virol 1999; 73: 352–361
   PubMed Web of Science ®Google Scholar
• He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D. CCR3 and CCR5 are co-receptors for HTV-1 infection of microglia. Nature 1997; 385: 645–649
   PubMed Web of Science ®Google Scholar
• Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lympho-tropic HIV-1 strains. J Virol 1998; 72: 8952–8960
   PubMed Web of Science ®Google Scholar
• Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 1999; 96: 8212–8216
   PubMed Web of Science ®Google Scholar
• Kelder W, Mc Arthur JC, Nance-Sproson T, Mc Clernon D, Griffin DE. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998; 44: 831–835
   PubMed Web of Science ®Google Scholar
• Klein RS, Williams KC, Alvarez-Hernandez X, Westmoreland S, Force T, Lackner AA, Luster AD. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J Immunol 1999; 163: 1636–1646
   PubMed Web of Science ®Google Scholar
• Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A. Identification of a T cell chemo-tactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 1999; 93: 172–181
   PubMed Web of Science ®Google Scholar
• Krachmarov CP, Chepenik LG, Barr-Vagel S, Khalili K, Johnson EM. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Purot. Proc Natl Acad Sci USA 1996; 93: 14112–14117
   PubMedGoogle Scholar
• Lane JH, Sasseville VG, Smith MO, Vogel P, Pauley DR, Heyes MP, Lackner AA. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J Neurovirol 1996; 2: 423–432
   PubMed Web of Science ®Google Scholar
• Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995; 268: 429–431
   PubMed Web of Science ®Google Scholar
• Li CJ, Ueda Y, Shi B, Borodyansky L, Huang L, Li YZ, Pardee AB. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc Natl Acad Sci USA 1997; 94: 8116–8120
   PubMed Web of Science ®Google Scholar
• Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 1998; 95: 14500–14505
   PubMed Web of Science ®Google Scholar
• Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999; 274: 17098–17102
   PubMed Web of Science ®Google Scholar
• Neumann M, Felber BK, Kleinschmidt A, Froese B, Erfle V, Pavlakis GN, Brack-Werner R. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1995; 69: 2159–2167
   PubMed Web of Science ®Google Scholar
• New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem 1998; 273: 17852–17858
   PubMed Web of Science ®Google Scholar
• Nielsen SL, Petito CK, Urmacher CD, Pasner JB. Subacute encephalitis in acquired immunodeficiency syndrome: A post-mortem study. Am J Clin Pathol 1984; 82: 678–682
   PubMed Web of Science ®Google Scholar
• Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, Mc Comb RD, Swindells S, Soderland C, Gendelman HE. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996; 156: 1284–1295
   PubMed Web of Science ®Google Scholar
• Nuovo GJ, Alfieri ML. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 1996; 2: 358–366
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997; 158: 3499–3510
   PubMed Web of Science ®Google Scholar
• Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, Mc Arthur JC, Trapp BD. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993; 34: 339–350
   PubMed Web of Science ®Google Scholar
• Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239: 586–592
   PubMed Web of Science ®Google Scholar
• Rappaport J, Joseph J, Croul S, Alexander G, Amini S, Khalili K. Molecular Pathway Involved in HIV-1 Induced CNS Pathology: Role of Viral Regulatory Protein, Tat. J Leuk Biol 1999; 65: 458–465
   PubMed Web of Science ®Google Scholar
• Rasty S, Thatikunta P, Gordon J, Khalili K, Amini S, Glorioso J. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc Natl Acad Sci USA 1996; 93: 6073–6078
   Google Scholar
• Rostad SW, Sumi SM, Shaw CM, Olson K, Mc Dougall JK. Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Res Hum Retroviruses 1987; 3: 363–373
   PubMedGoogle Scholar
• Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL. Chemokines and receptors in HIV encephalitis. AIDS 1998; 12: 1021–1026
   PubMed Web of Science ®Google Scholar
• Sasseville VG, Smith MM, Mackay CR, Pauley DR, Mansfield KG, Ringler DJ, Lackner AA. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol 1996; 149: 1459–1467
   PubMed Web of Science ®Google Scholar
• Sawaya BE, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S. Regulation of TNFa and TGF/M gene transcription by HIV-1 Tat in CNS cells. J Neuroimmunol 1998; 87: 33–42
   Google Scholar
• Schmidtmayerova H, Nottet HS, Nuovo G, Raabe T, Flanagan CR, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996; 93: 700–704
   PubMed Web of Science ®Google Scholar
• Sharer LR, Kapila R. Neuropathologic observations in the acquired immunodeficiency syndrome. Acta Neuropathol (Berl) 1985; 66: 188–198
   PubMedGoogle Scholar
• Strijbos PJ, Zamani MR, Rothwell NJ, Arbuthnot G, Harkiss G. Neurotoxic mechanisms of transac-tivating protein Tat of Maedi-Visna virus. Neurosci Lett 1995; 197: 215–218
   PubMed Web of Science ®Google Scholar
• Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K. Transactivation of the JC virus late promoter by the Tat protein of type-1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 1990; 87: 3479–3483
   PubMed Web of Science ®Google Scholar
• Tornatore C, Meyers K, Atwood W, Conant K, Major EO. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994; 68: 93–102
   PubMed Web of Science ®Google Scholar
• Viscidi RP, Mayur K, Lederman HM, Frankel AD. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989; 246: 1606–1608
   PubMed Web of Science ®Google Scholar
• Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998; 92: 451–462
   PubMed Web of Science ®Google Scholar
• Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol 1998; 152: 659–665
   PubMed Web of Science ®Google Scholar
• Zagury J-F, Lachgar A, Bizzini B, Astgen A, Lecoq H, Fouchard M, Chams V, Feldman M, Richardson M, Rappaport J, Burny A, Zagury D, Gallo RC. A critical role of Tat and IFNα in the HIV-1 induced immunosuppression leading to AIDS. AIDS Sciences 1996; 3: 104–108
   Google Scholar
• Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury J-F, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, Burny A, Gallo RC. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA 1998a; 95: 3851–3856
   PubMed Web of Science ®Google Scholar
• Zagury J-F, Abderrahim-Lachgar A, Le Buanec H, Rappaport J, Hendel H, Bizzini B, Gringeri A, Carcagno M, Criscuolo M, Burny A, Blattner W, Gallo RC, Zagury D. Antibodies to the HIV-1 Tat protein correlate with non-progression to AIDS: a rationale for the use of a Tat toxoid as an HIV-1 vaccine. J Hum Virol 1998b; 1: 282–292
   PubMedGoogle Scholar
• Zauli D, Davis BR, Re MC, Visani G, Furlini G, La Placa M. Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1 induced hematopoietic suppression. Blood 1992; 80: 3036–3043
   PubMed Web of Science ®Google Scholar
• Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM, Gendelman HE. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 1999; 98: 185–200
   PubMed Web of Science ®Google Scholar